Bio-Optronics Introduces CCTrialSuite

Article

Applied Clinical Trials

Bio-Optronics unveiled the launch of CCTrialSuite, a comprehensive set of integrated, patient-centric clinical research management products to further streamline research operations while maintaining a high degree of compliance. The company announced the introduction of the first two CCTrialSuite products in the family complementing its industry-leading Clinical Conductor CTMS: 

CCPay, a fully integrated comprehensive payment solution offering sites the unprecedented ability to service patients with real-time payment reimbursements using secure pre-paid patient payment cards. 

CCText, an advanced text messaging solution for clinical research sites designed to boost patient recruitment, engagement, and retention with 2-way messages to participants. CCText is the only CTMS-integrated, 2-way text messaging solution available to research sites. 

“CCTrialSuite is designed to be the first solution in the industry providing the breadth of integrated tools required to run the world’s best research that does not compromise on functional depth,” states Max Elbaz, Chief Commercial Officer at Bio-Optronics. 

Focused on dynamic patient-centric needs and coupled with the industry’s most efficient internal business operations capabilities, CCTrialSuite is a solution for research facilities around the world to offer connected applications enhancing trial patients’ experience, supporting research business growth and ensuring compliance. 

Central to the CCTrialSuite is the Clinical Conductor CTMS, which is used by thousands of clinical research sites around the world to simplify, standardize complex research processes to expand business efficiencies, compliance and advance patient experience. 

Bio-Optronics is highlighting CCTrialSuite at ACRP Annual Conference, April 12-14, in Nashville, TN. All solutions can be seen by visiting booth #134 in the exhibit hall. 

 

For more information, visit www.bio-optronics.com or follow @BioOptronics on Twitter or LinkedIn 

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.